We are live on
!
Find out more
Bioventus
BVS
BVS
84 hedge funds and large institutions have $178M invested in Bioventus in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
5% more funds holding
Funds holding: 80 → 84 (+4)
8% more call options, than puts
Call options by funds: $998K | Put options by funds: $925K
1% more capital invested
Capital invested by funds: $176M → $178M (+$1.5M)
0.83% more ownership
Funds ownership: 53.18% → 54% (+0.83%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
84
Holders Change
+4
Holders Change %
+5%
% of All Funds
1.21%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
28
Reduced
22
Closed
14
Calls
$998K
Puts
$925K
Net Calls
+$73K
Net Calls Change
-$534K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.53M |
| 2 |
Jane Street
New York
|
+$1.12M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$1.1M |
| 4 |
Goldman Sachs
New York
|
+$879K |
| 5 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$744K |
